MEDITECH to Integrate NCCN Chemotherapy Order Regimens into Web EHR

Clinicians will have access to NCCN Chemotherapy Order Templates (NCCN Templates ®) as standard content within MEDITECH’s Web EHR, providing clinically-sophisticated treatment plans and decision support.

(Westwood, Mass.) — In collaboration with the National Comprehensive Cancer Network® (NCCN®), MEDITECH, a leading Electronic Health Record (EHR) vendor, will embed the NCCN Templates® as standard content within the Web EHR for actionable, integrated CPOE ordering, while also providing links to corresponding NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for additional decision support. NCCN Templates® include chemotherapy and immunotherapy regimens, along with literature support, supportive care agents, monitoring parameters, and safety instructions.

“NCCN’s collaboration with MEDITECH further ensures that practitioners have access to timely, unbiased clinical treatment protocols at the point of care so they can provide patients with the most appropriate regimens for their diagnosis,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN.

By standardizing patient care, reducing medication errors, anticipating and managing adverse events, and ensuring patient safety, these NCCN Templates will be an integral part of raising the standard of care provided by clinicians using MEDITECH.

“MEDITECH’s collaboration with the NCCN is a major part of the company’s strategy to help clinicians streamline oncology care to better treat their patients,” says Hoda Sayed-Friel, Executive Vice President of Strategy, MEDITECH. “We’re thrilled to be including these regimens into our standard content to enhance patient safety and help guide clinicians’ cancer treatment efforts by providing up-to-date, evidence-based standard protocols and best practices within MEDITECH’s Oncology Management solution.”

As part of the NCCN’s primary goal to develop Templates for enhancing patient safety, NCCN continues to expand their library of chemotherapy order templates in an effort to improve safe and effective use of drugs and biologics in cancer care. The information contained in the NCCN Templates is based on the NCCN Guidelines® and the NCCN Drugs & Biologics Compendium (NCCN Compendium®). For more information about NCCN, as well as the NCCN Guidelines and Templates, visit

Healthcare is long overdue for genuine disruption and innovation. MEDITECH is helping care organizations to reclaim their productivity, coordinate care, and do more for patients with its mobile Web Electronic Health Record (EHR). With 2,400+ customers, across 22 different countries, MEDITECH solutions are empowering users to provide higher quality care, with greater efficiency, to more people, at a lower cost. A leading EHR vendor with over 45 years of experience, MEDITECH is helping care organizations reach their clinical, analytical, and financial goals. For more information on how MEDITECH is transforming healthcare and building the next generation of EHR leaders, go to

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The NCCN Core Values represent the principles that we, the NCCN team, strive to embrace. As representatives of leading cancer centers, we believe that by exemplifying these ideals within our organization, we can improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. For more information, visit